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Background: There is a recent resurgence in the use of intrauterine insemination (IUI) in Nigeria. However, there is a need 
for a rational use of the procedure so that couples do not waste time and money on ineffective therapy if it is not indicated.
Objective: The objective of this study was to identify the possible prognostic factors affecting outcome of IUI among patients 
undergoing the procedure.
Patients and Methods: This is a retrospective review of the case files and treatment protocols of fifty consecutive couples 
who had IUI procedure following the established diagnosis of Infertility at the Paramount Fertility Center of Paramount 
Specialist Hospital Ondo, Nigeria, over a period of 1 year (February 2016 to January 2017).
Results: There were ten (20.0%) pregnancies recorded, of which three (6%) clients had first‑trimester miscarriages 
(between the 5th and 13th weeks), one (2%) had an ectopic pregnancy, whereas six (12%) were carried to the age of viability 
and delivered. Forty (80%) clients did not achieve pregnancy. The postwash concentration of sperm was noticed to be the 
only parameter significantly affecting the rate of pregnancy in our treatment cycles with P < 0.05. There was also a trend 
toward a reduction in pregnancy after the age of 40.
Conclusion: This study shows that the postwash sperm count and age of the female have the most predictive value for IUI 
clinical pregnancy outcome in our center.
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Introduction
Intrauterine insemination (IUI) is a procedure that places 
washed active sperm past the cervix and in a woman’s uterus 
around the time of ovulation. This makes the journey to the 
fallopian tubes much shorter, and there is a better chance that 
more sperm will encounter the egg. The goal of this procedure 
is to improve a woman’s chance of getting pregnant.
The use of intrauterine artificial insemination for the 
management of infertility underwent a decline following 
the emergence of the human immunodeficiency virus (HIV) 
as well as the complications associated with the use of neat 
semen.
Sperm preparation methods developed for in vitro 
fertilization (IVF) and embryo transfer, such as the wash, 
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swim-up and swim-down techniques, and the use of density 
gradients, have led to a resurgence of interest in IUI. The 
use of washed prepared sperm for IUI has also resulted in a 
significant reduction in the side effects associated with the 
use of neat semen for IUI (which never should be used), such 
as painful uterine cramps, collapse, and infection.[1]
This resurgence has led to the abuse of the procedure in 
patients who will not benefit from the procedure, leading to 
unnecessary psychological and/or financial burden.
This study reports on the outcome of fifty consecutive IUIs at 
a private health facility in Nigeria with the aim of documenting 
prognostic factors that can be used in decision-making and 
patient counseling.
Patients and Methods
Couples who had IUI treatment following the established 
diagnosis of Infertility at the Paramount Fertility Center of 
Paramount Specialist Hospital Ondo, Nigeria, over a period 
of 1 year (February 2016 to January 2017) were enrolled in 
the study.
This is a retrospective review of the case files and treatment 
protocols of couples who had IUI procedure during the study 
period.
The IUI treatments were performed after patients were 
adequately counseled, and written consent was obtained and 
then recruited for the procedure before ovulation induction 
was commenced.
A baseline serum concentration of luteinizing hormone (LH), 
follicle-stimulating hormone (FSH), prolactin, and estradiol 
on day 2 or day 3 of the menstrual cycle preceding the 
treatment cycle was done to assess the ovarian reserve. 
A hysterosalpingography was also performed on day 10 of the 
menstrual cycle to assess the tubal patency, and a baseline 
semen analysis was done to assess the sperm count. Couples 
were also screened for HIV, hepatitis B and C, and syphilis 
using the Venereal Disease Research Laboratory test. The 
blood group and haemoglobin genotype was performed for 
patients considering donor sperm so as to be able to choose 
the appropriate semen from the sperm bank.
The semen was collected preferably by masturbation (or 
coitus interruptus with spermicide-free condoms where 
masturbation was not possible) about 35 h after human 
chorionic gonadotropin (HCG) trigger. Sperm wash technique 
with SpermGrad (Vitrolife Sweden AB, Goteborg Sweden) 
gradient sperm preparation medium was used for 10 min at 
2500 rpm. The final sample was simply washed with G-MOPS 
PLUS (Vitrolife Sweden AB, Goteborg Sweden) for 5 min at 
2500 rpm and incubated at 37°C for 5 min before insemination.
The patients were placed in lithotomy position; cleaning 
of the perineum, vulva, and vagina was done with normal 
saline, and a sterile speculum was inserted to expose the 
cervix. Air was withdrawn into the IUI catheter (SUNN IUI 
SAR Healthline (P) Ltd., India) to serve as an air plug before 
drawing the prepared sperm to prevent regurgitation. The 
sperm(0.3-0.5ml) was then injected into the uterus slowly 
and the catheter withdrawn when pushing the air plug. 
The patients were under rest for 15 min in Trendelenburg 
position after insemination. Normal sexual intercourse was 
encouraged within the next 72 h.
The luteal-phase support was commenced on the 5th day 
postinsemination with intramuscular hydroxyprogesterone 
caproate (Proluton Bayer Schering Pharma, Germany) 250 mg 
depot. Biochemical pregnancy was determined by maternal 
serum HCG level on day 15 postinsemination, while clinical 
pregnancy was confirmed by ultrasound detection of a 
gestational sac at 4 weeks’ postinsemination.
Our primary end point was the live birth rate (per insemination), 
and the secondary end points were chemical and clinical 
pregnancy rates and spontaneous miscarriage rates. The 
data regarding pregnancy follow-up and delivery were also 
extracted.
Ovulation induction protocols included clomiphene 
citrate (CC) 100 mg daily for 6 days (Ovumine, Baroque 
Pharmaceuticals Pvt. Ltd., India) alone, or in combination 
with metformin 500 mg twice daily for 10 days or letrozole 
2.5 mg daily for 6 days, and controlled ovarian hyperstimulation 
(COH) with human menopausal gonadotropin (HMG IVF-M 
injection menotropin, LG Life Sciences) 75 IU daily for 10 days 
starting from day 2 to day 5 of the menstrual cycle. Ancillary 
medications given include M2-Tone Herbal one tablet twice 
daily for 10 days (Charak Pharma Pvt. Ltd., India) and folic 
acid 5 mg daily. The ovarian response to stimulation was 
monitored by transvaginal ultrasound assessment of follicular 
and endometrial growth on days 9 and 11 of menstrual 
cycle. A pre-HCG scan was done on day 11 or day 12 and 
ovulation was triggered by a single injection of 5000 IU of 
HCG (Diclair-HP HCG, R Germany) when at least a matured 
sized follicle or more had reached the diameter of 18 mm or 
more and trilaminar endometrial thickness of 8–12 mm. IUI 
was then carried out between 36 and 40 h post-HCG trigger.
The results were analysed by Statistical Package for the Social 
Sciences (SPSS) software version 17.0  SPSS Inc. Chicago 
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IL, USA. The results were presented as mean ± standard 
deviation. The statistical significance of differences between 
groups for continuous variables was assessed and differences 
in proportions were assessed using Mantel–Haenszel’s test 
or Fisher’s exact test, where appropriate. P < 0.05 was 
considered statistically significant.
Results
Between February 2016 and January 2017, fifty procedures 
were done in the IUI section of the fertility center. There were 
ten (20.0%) pregnancies recorded, of which three (6%) clients 
had miscarriages between 5th and 13th weeks of gestation. 
One (2%) had an ectopic pregnancy, whereas six (12%) were 
carried to the age of viability and delivered. Forty out of the 
fifty (80%) clients did not achieve pregnancy. The details are 
summarized in Table 1.
Table 2 shows the relationships between the various factors and 
pregnancy rates. The mean female age was 33.8 ± 7.9 years.
Cause of infertility was ovulatory in 18%, tubal factor (one 
patent fallopian tube) in 14%, cervical factor in 10%, male 
factor in 26%, and unexplained in 32% of the patients. The 
postwash concentration of sperm was noticed to be the only 
parameter significantly affecting the rate of pregnancy in our 
treatment cycles with P < 0.05.
Discussion
In our study, we made an effort to determine the prognostic 
factors that would determine the success of ovulation induction 
and IUI. The variables selected were patients’ parameters such 
as age of the woman, parity, cause of infertility, choice of 
ovulation induction agent, insemination time post-HCG trigger, 
and concentration of semen. Parameters related to ovulation 
induction included number of follicles and endometrial 
thickness. Laboratory parameters such as days of abstinence, 
postwash motility, and morphology were recorded.
Among the patients’ parameters, female age is important as 
declining oocyte quality associated with increasing age is 
well documented.[2] Even more effective treatment options 
such as IVF cannot completely overcome the negative 
impact of age.[3] In our study, the trend toward reduction 
in success rate with ovulation induction and IUI was noted 
in women aged >40 years, although the difference was 
not statistically significant. However, many studies have 
documented a significant drop in the success rate beyond 
the age of 40 years, with reported live births being as low 
as 1.4%.[4] Put together, for women over 35 years, ovulation 
induction and IUI as a treatment option need careful 
consideration, and for women over the age of 40, IUI is a 
poor treatment option.
Table 2: Factors affecting the pregnancy rates in intrauterine 
insemination
Parameters Outcome Frequency (%) P
Nonpregnant Pregnant
Female age (years)
20‑24 1 0 1 (2) 0.490
25‑29 4 3 7 (14)
30‑34 15 3 18 (36)
35‑39 17 4 21 (42)
40‑44 3 0 3 (6)
Parity
0 29 10 39 (78) 0.317
1 6 0 6 (12)
2 4 0 4 (8)
3 0 0 0 (0)
4 1 0 1 (2)
Cause of infertility
Ovulatory 8 1 9 (18) 0.749
Tubal 6 1 7 (14)
Cervical 3 2 5 (10)
Male 10 3 13 (26)
Unexplained 13 3 16 (32)
Ovulation induction agent
CC alone 15 4 19 (38) 0.987
CC + metformin 7 2 9 (18)
CC + letrozole 3 1 4 (8)
Letrozole + metformin 1 0 1 (2)
HMG 13 3 16 (32)
Natural cycle 1 0 1 (2)
Insemination time (h) 
post‑HCG
<36 1 0 1 (2) 0.845
36‑38 12 3 15 (30)
38‑40 25 7 32 (64)
>40 2 0 2 (4)
Postwash sperm 
concentration (million/ml)
<20 6 0 6 (12) 0.006
21‑40 10 1 11 (22)
41‑60 3 0 3 (6)
61‑80 10 0 10 (20)
81‑100 7 3 10 (20)
>100 4 6 10 (20)
HCG – Human chorionic gonadotropin; HMG – Human menopausal gonadotropin; 
CC – Clomiphene citrate





Live birth 6 (12.0)
Total 50 (100.0)
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No difference was noted in the success rate with regard to 
the cause of infertility. Among indications for IUI, the success 
rate was higher in male factor (use of a donor sperm) and 
unexplained infertility as compared with tubal and ovulatory 
factors, although the difference did not reach statistical 
significance. Some studies found that unexplained factors 
have a better prognosis in clinical pregnancy compared to 
other etiological factors.[5] However, some studies noted that 
moderate male factors and anovulation have the highest 
clinical pregnancy rates in IUI.[6]
An unexplained infertility couple may have problems with 
egg quality, the ability of the sperm to fertilize the egg, 
undiagnosed tubal dysfunction, implantation failure, or 
genetic causes.[7] Ovarian factors may be related to elevated 
LH levels that affect the egg quality by resumption of early 
meiosis and premature oocyte maturation that will lead to 
inability to be fertilized or miscarriages.[8]
Ovarian stimulating agents for COH affected the clinical 
pregnancy rate of IUI. It has been observed that the chances 
of getting pregnant in IUI using COH were double with the 
addition of COH compared with IUI alone.[9] The drug regimens 
that are mainly used for IUI were CC and gonadotropins (rFSH, 
HMG, and HCG).[10] In our center, we used CC alone or in 
combination with metformin or letrozole. We also use 
HMG alone or in combination with other drugs for ovarian 
stimulation. In most of the studies, the use of gonadotropins 
has a better clinical pregnancy rate compared to CC.[6] 
However, this regimen would increase the risk of multiple 
pregnancies and ovarian hyperstimulation syndrome (OHSS). 
Therefore, the use of gonadotropin in unexplained factors 
may not be appropriate for these reasons.[11]
Minimal stimulation using combination of both CC and 
gonadotropins in IUI seems to be the ideal regimen. This 
protocol could reduce the risk of multiple pregnancies and 
achieve the main objective of obtaining a few dominant 
follicles with less complication of OHSS.
Another important prognostic factor for IUI success is 
the sperm quality. We assessed our results based on the 
sperm concentration which had significant influence 
on the clinical pregnancy rate. Our study showed 
that patients with sperm concentration >80 million 
had a better outcome. This proves that male patients 
with ol igozoospermia ( low count in sperm) and 
asthenozoospermia (low progressive motility in sperm) 
were associated with a poor outcome. IUI is not a 
good option for these patients. Intracytoplasmic sperm 
injection (ICSI) during IVF should be considered instead.
There was a significant difference in the clinical pregnancy 
rate when postwash sperm concentration was >80 million/ml 
(P = 0.006). In most studies, the density gradient method 
has been shown to confer advantages in sperm recovery 
compared to swim-up method. This method not only yields 
the highest number of motile sperm but also reduces 
the bacterial contamination and processing time.[12] 
Furthermore, this technique has a higher percentage of 
morphological sperm recovery, better DNA quality, and 
chromatin packaging.[13-15]
There are many studies that stated the suitable number of 
sperm recovery after preparation. The minimum number of 
motile sperm varies from 0.8 to 10 million/ml.[16,17] In our 
cases, patient with normal sperm count had a good recovery 
of motile washed sperm compared with  patients with low 
sperm count. However, the sperm recovery after postwash 
for oligozoospermia patients in gradient method did not 
improve the count and motility.
Conclusion
Ovulation induction and IUI are important treatment 
options for varied indications, especially when female age 
is <35 years. Definitive prognostic factors for predicting 
success will help in counseling patients regarding the 
modality of treatment. We concluded that the female age and 
sperm count have the most predictive value for IUI clinical 
pregnancy outcome in our center. Other factors such as type 
of infertility, etiological factors, stimulation protocol, timing 
of insemination, and parity do not have a significant effect on 
the IUI successful rate. Hence, female patients with advanced 
age and male patients with low sperm count would benefit 
from IVF/ICSI rather than IUI.
Study limitations
A limitation of the study is the retrospective design. 
Although the sample size is small, our study provides 
an important finding/evidence that there is good clinical 
pregnancy with an increased sperm concentration in IUI 
procedures in Nigeria. Another limitation of the study is the 
fact that there was no uniformity in the ovulation protocol 
used. We did not assess cycle cancelation rates or OHSS 
rates. Further studies with larger series of women are 
needed to confirm these useful findings in our low-resource 
setting.
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